Trial Profile
Decitabine for Myelodysplastic Syndromes and Acute Myeloid Leukemia Before Allogeneic Hematopoietic Cell Transplantation
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Mar 2013
Price :
$35
*
At a glance
- Drugs Decitabine (Primary)
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- Acronyms DFMBHSCT
- 16 Mar 2013 New trial record